Zidebactam
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02707107)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- PBP2INHIBITOR
Q9R744 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- wck 5222
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03554304 | Phase 1 | Feb 9, 2017 | Wockhardt |
| NCT02942810 | Phase 1 | Oct 1, 2016 | Clinartis, Wockhardt |
| NCT02707107 | Phase 1 | Mar 1, 2016 | IQVIA, Wockhardt |
Showing 3 of 3 trials
Page 1 / 1